Spero Therapeutics, Inc. ($SPRO)
Filing Information
| Accession Number | 0001193125-26-209884 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
25,240
Total Value
$63,352.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Common Stock | โ | May 4, 2026 | Sale | 25,240 | $2.51 | $63,352.40 | 986,851 | Direct | โ | View Details |